Table 2.
Correct knowledge/awareness about COVID-19 pandemic among urban and rural respondents of Bangladesh (n = 1520).
| Knowledge Items | Rural | Urban | ||||
|---|---|---|---|---|---|---|
| n | % (95% C.I) | n | % (95% C.I.) | Total n (%) | p-Value | |
| Total respondents | 911 | 59.9 | 609 | 40.1 | 1520 (100.0) | |
| Transmission modes | ||||||
| k1. Contact with respiratory droplets | 483 | 53.0 (49.8–56.2) | 405 | 66.5 (62.7–70.2) | 888 (58.4) | <0.01 * |
| k2. Touching and shaking hands with an infected person | 781 | 85.7 (83.3–87.9) | 565 | 92.8 (90.5–94.6) | 1346 (88.5) | <0.01 * |
| k3. The use of objects used by an infected person | 672 | 73.8 (70.8–76.5) | 501 | 82.3 (79.1–85.1) | 1173 (77.1) | <0.01 * |
| k4. Sexual route | 281 | 30.8 (27.9–33.9) | 201 | 33.0 (29.4–36.8) | 482 (31.7) | 0.399 * |
| k5. Person-to-person | 704 | 77.3 (74.5–79.9) | 479 | 78.7 (75.3–81.8) | 1183 (77.8) | 0.571 * |
| k6. Close contact | 632 | 69.4 (66.3–72.3) | 465 | 76.4 (71.9–79.6) | 1097 (72.1) | <0.01 * |
| Signs and symptoms | ||||||
| k7. Fever | 875 | 96.0 (94.9–97.2) | 587 | 96.4 (94.7–97.7) | 1462 (96.0) | 0.786 * |
| k8. Tiredness | 459 | 50.4 (47.1–53.1) | 339 | 55.7 (51.7–59.6) | 798 (52.5) | <0.05 * |
| k9. Dry cough | 780 | 85.6 (83.2–87.8) | 551 | 90.5 (88.0–92.6) | 1331 (87.5) | <0.01 * |
| k10. Shortness of breath/Breathing difficulties | 696 | 76.4 (73.6–79.1) | 544 | 89.3 (86.7–91.6) | 1240 (81.5) | <0.01 * |
| k11. Aches and pains | 433 | 47.5 (44.3–50.8) | 311 | 51.1 (47.1–55.0) | 744 (48.9) | 0.191 * |
| k12. Nasal congestion | 261 | 28.6 (25.8–31.7) | 223 | 36.6 (32.9–40.5) | 484 (31.8) | <0.01 * |
| k13. Running nose | 315 | 34.6 (31.5–37.7) | 216 | 35.5 (31.7–39.3) | 531 (35.0) | 0.742 * |
| k14. Sore throat | 348 | 38.2 (35.1–41.4) | 326 | 53.5 (49.6–57.5) | 674 (44.3) | <0.01 * |
| k15. Diarrhea | 447 | 49.1 (47.7–54.2) | 335 | 55.0 (51.0–58.9) | 782 (51.4) | <0.05 * |
| Treatments/prevention | ||||||
| k16. The incubation period (2 weeks) | 786 | 86.3 (83.9–88.4) | 561 | 92.1 (89.8–94.1) | 1347 (88.6) | <0.01 * |
| k17. COVID-19 vaccines, drugs, or treatments is available | 686 | 75.3 (72.4–78.0) | 477 | 78.3 (74.9–81.5) | 1163 (76.5) | 0.068 * |
| k18. Lock-down | 475 | 52.1 (48.9–55.4) | 415 | 68.1 (64.4–71.8) | 890 (58.5) | <0.01 * |
| k19. Self-isolation | 417 | 45.8 (42.6–49.0) | 355 | 58.3 (54.3–62.2) | 772 (50.7) | <0.01 * |
| k20. Home quarantine | 770 | 84.5 (82.1–86.8) | 505 | 82.9 (79.8–85.8) | 1275 (83.8) | 0.434 * |
| Summarized knowledge about COVID-19 | <0.01 * | |||||
| Good | 226 | 24.8 (22.1–27.7) | 218 | 35.8 (32.1–39.7) | 444 (29.2) | |
| Poor | 685 | 75.2 (72.3–77.9) | 391 | 64.2 (60.3–67.9) | 1076 (70.8) |
All p-values are based on a Chi-square test of numbers in urban and rural categories except those indicated by an asterisk (*) which are based on Fisher’s exact test. Scores considered (≥80 = good and <80 = poor).